| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.067 | 0.05 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | -0.066 | 0.05 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.068 | 0.06 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | -0.057 | 0.06 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | -0.093 | 0.06 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.06 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.06 | 0.06 |